There is a growing interest in the treatment of endotoxin shock with vasodilating agents. Reports vary as to the relative success of employing drugs such as Apresoline (1-hydrazinophthalazine) (1, 2) and Dibenzyline (phenoxybenzamine) (3, 4) in the treatment of this form of shock. Although most of the work indicates that in the experimental animal increased survival is effected (1) (2) (3) (4) (5) (6) , others (7) have shown that large doses of phenoxybenzamine actually decrease survival time. The peripheral pooling, stagnation of blood flow, tissue anoxia, and decreased renal function so commonly observed during shock (5, 8, 9) appear to be somewhat improved with vasodilator therapy (4, 5, 10, 11) . Limited observations in the human also suggest beneficial effects of such treatment (12, 13) , yet definitive studies are lacking and data obtained in the dog may not be transposed to the human. The present study was carried out to assess the effectiveness of phenoxybenzamine in the treatment of endotoxin shock in the monkey and to bridge the gap which naturally exists between data obtained in the dog and that which is applicable to man.
Methods
Seventeen adult male and female monkeys of the Cynapithecoid group, Cercocebus torquatus Atys (sooty mangabey), were used in the present study. Animals were anesthetized with ether followed by Surital sodium (thiamylal sodium), given intravenously, in amounts to maintain a surgical stage of anesthesia between planes I and II. Mean systemic blood pressures were obtained by electrical integration and recorded by means of a Statham strain gauge and a Sanborn direct writer.
In the six animals comprising group I, blood pressure, respiratory rate, urine output, hematocrit, and arterial blood pH were determined at hourly intervals before and for 9 hours after a lethal injection of purified Escherichia coli endotoxin 1 (7.5 mg per kg). Each * Submitted for publication August 16, 1963 Tables I and II . Average values for blood pressure, respiratory rate, urine output, hematocrit, and blood pH observed at hourly intervals in the control and the treated groups of monkeys are shown in Figure 1 . The three untreated animals showed progressive hypotension, hyperpnea, oliguria, and anuria after endotoxin. Slight increases in hematocrit and a slow progressive fall in blood pH were also noted. quently developed oliguria and expired 7 hours after endotoxin. The average survival time of this group was 10.8 hours. The five treated animals showed marked recovery in renal parameters within 1 hour after having received the phenoxybenzamine. UO, RPF, and GFR returned to normal or near normal values even after periods of reduced function. The EPAH was also somewhat improved with treatment. All animals in this group survived for 72 hours after having received endotoxin and were sacrificed because of experimental design.
Discussion
Renal failure and decreased peripheral vascular flow are two of the factors contributing to the irreversibility of endotoxin shock (5, 8, 9) . The mechanism by which renal shutdown and tissue anoxia occur remains vague in spite of the intense efforts of certain investigators (14, 15) . The present study emphasizes the importance of maintaining adequate kidney perfusion and flow to vital tissue during shock. This is impossible in untreated endotoxin shock where the liberation of large amounts of endogenous catecholamines and histamine results in a reduction of flow to vital tissues of the body (16, 17) . This decrease in flow is thought to be the combined result of a catecholamine-induced arteriolar vasoconstriction and a histamine-induced' venospasm (18). Although the effect of phenoxybenzamine in increasing flow may occur at the expense of pressure, survival data indicate that this is consistent with adequate perfusion of vital tissues and decreased mortality. Renal parameters are also improved with this therapy, and the kidneys appear adequately perfused. The exact mechanism by which phenoxybenzamine favorably influences renal hemodynamics and survival in endotoxin shock is not known, but is most probably due to inhibition of catecholamine and histamine action on peripheral vessels (19) . These studies were carried out in the primate and the parameters followed might be of clinical importance in the evaluation and treatment of endotoxin shock in the human.
The apparent conflict between the concept of treatment suggested in this study and that previously reported in which adrenal steroids and vasoconstrictor agents were employed as shock therapy is as yet unresolved (20, 21) . This dilemma, however, appears prevalent among many investigators (22, 23) . Summary The growing interest in the use of vasodilator agents in the treatment of endotoxin shock has prompted the present investigation. Seventeen monkeys were used to study the effects of a lethal injection of endotoxin and subsequent treatment with phenoxybenzamine on renal function and survival in the primate. Progressive hypotension, decreased renal function, and hyperpnea were consistently noted after endotoxin. Results indicate the effectiveness of vasodilator therapy in this form of shock. Renal parameters, such as renal plasma flow, glomerular filtration rate, and the extraction ratio of para-aminohippurate, recover to near normal levels as do the urine output, blood pH, and respiratory rate. Although blood pressure may be maintained at a somewhat lower level with this therapy, results indicate that this is consistent with adequate kidney perfusion and increased survival. The current dilemma of vasoconstrictor versus vasodilator therapy in the treatment of endotoxin shock is noted.
